End-of-dose "wearing-off" is commonly experienced by Parkinson's disease (PD) patients who have used dopaminergic therapy for several years.
•Inclusion criteria: ever experienced resting tremors and at least one of the following symptoms due to their Parkinson's disease: slowed ability to start and continue movements; rigidity or the inability to complete a movement, stiffness; difficulty with balance, instability; stooped, forwardleaning posture; freezing or sudden, brief inability to move the feet. Exclusion criteria: self reported history of brain surgery to treat PD symptoms; declined consent.
•Frequency of "off-time" was measured using the Unified Parkinson's Disease Rating Scale Part IV. •Parkinson's Disease [3]: 8-item questionnaire measuring the physical and psychosocial impact of PD. Although each item represents one domain, a summary score based on all 8 items -the PDQ-8 Summary Index (PDQ-8 SI) -can be derived.
Measures
The PDQ-8 SI was evaluated as the sum of the 8 items divided by the maximum possible score (32), expressed as a percentage.
•Wearing off [4]: The "wearing-off" Questionnaire -9 [4] is a 9-item survey that asks about the reduction of or improvement of PD symptoms in relation to the timing of medication. For each symptom, the respondent is first asked whether they experience the symptom (Yes/No). Respondents who answer "Yes", are then asked whether the symptom is reduced or disappears after taking the next dose of PD medication (Yes/No).
WOQ-9 scores were derived using the following calculations:
i.the number of symptoms that are present on a normal day, evaluated as the sum of affirmative answers to question 1;
ii.the total number of fluctuating symptoms, evaluated as the number of affirmative answers to question 2, provided the respondent also answered Yes to question 1 for the same item;
Sample Characteristics
Key demographic and clinical characteristics are presented in Table 1 .
Differences in Health Status Between Stable PD patients and Fluctuators
•SF12v2 summary scores showed significantly greater impairment in physical health (p<0.01) and mental health (p=0.02) for fluctuators when compared to stable patients ( Table 2 ). The scores of fluctuators were 0.5 standard deviations below average SF12v2 scores for individuals aged 65-74 years, in the general US population [2].
•The mean PDQ-8 SI of stable subjects was nearly 5 points lower than the mean of PD patients with fluctuations (p < 0.01; Table 2 ).
•The mean number of self-reported symptoms in the WOQ-9 was significantly higher (+1) among fluctuators, as was the mean number of symptoms improving after medication (+1.6).
•Differences in specific PD symptoms (Figure 1) , as captured by the WOQ-9, didn't reach statistical significance, with the exception of stiffness (stable: 46%; fluctuator: 70%; p=0.019). Statistically significant differences were observed in symptoms which improve after taking the medication: tremor (stable: 43%; fluctuators: 85%; p<0.001), reduced dexterity (stable: 31%; fluctuators: 64%; p=0. 012) and cloudy mind (stable: 39%; fluctuators: 63%; p=0.036).
RESULTS

LIMITATIONS
•Online recruitment of participants could have introduced bias by excluding individuals lacking appropriate skills and/or resources.
•The presence of "off-time"-time was self-reported which could have caused misclassification and/or differed from clinician assessed presence of "off-time"-time.
•Cross-sectional study design. 
CONCLUSIONS
•PD patients who experienced at least some "off-time" on a typical day (fluctuators) reported worse overall physical and mental well-being than stable patients.
•Both motor and non-motor "wearing-off" symptoms differed between the two patient groups.
•Additional research to understand the consequences of "off-time" would be useful, especially as it pertains to non-motor symptoms. 
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